Daniel Griffin was Appointed as Sr Director Total Rewards at Ironwood Pharmaceuticals

Date of management change: September 10, 2019 

What Happened?

Cambridge, MA-based Ironwood Pharmaceuticals Appointed Daniel Griffin as Sr Director Total Rewards


About the Company

At Ironwood Pharmaceuticals (NASDAQ: IRWD) our vision is clear: to bring new, differentiated therapies to the millions of patients who live with GI diseases. Building on a strong, decades-long foundation, the next leg of our journey continues with three innovative assets. Our in-market product, LINZESS® (linaclotide), discovered in-house, is the branded prescription market leader in its class. We are also pioneering the science behind our two development programs, IW-3718 and MD-7246, which aim to address two highly symptomatic GI conditions with significant unmet needs. Ironwood was founded in 1998 out of the Whitehead Institute for Biomedical Research, an affiliate of Massachusetts Institute of Technology (MIT), and we remain headquartered in the vibrant biotech community of Cambridge, Mass. Each of our employees holds equity in the company, which means we all share the responsibility to help Ironwood succeed.


About the Person

Daniel Griffin is Sr Director Total Rewards at Ironwood Pharmaceuticals. Previously, Daniel held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Ferrer Marie, Arsikere Amar, Hoffman Jason, Bubas David, Lee Clare, Bonine Karol, Jacobs Jennifer, Spitzer Mark, Michalak Kristin, McCain Andrea, Sickmann Tricia

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.